EUVIMEDEUVIMED entdecken
Crossref

Interference of ATP‐Adenosine Axis by Engineered Biohybrid for Amplifying Immunogenic Cell Death‐Mediated Antitumor Immunotherapy

Xin-Chen Deng, Jun-Long Liang, Shi-Man Zhang, Yu-Zhang Wang, Yan-Tong Lin, Ran Meng, Jia-Wei Wang, Jun Feng, Wei-Hai Chen, Xian-Zheng Zhang iD

Advanced Materials · 2024-09 · 36 (36)

DOI: 10.1002/adma.202405673 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 18.07.2024. Verfasst von Xin-Chen Deng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan, 430072, P. R. China. Hauptthemen laut MEDLINE: Adenosine, Adenosine Triphosphate, Immunogenic Cell Death, Immunotherapy. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Translational Medicine and Interdisciplinary Research Joint Fund of Zhongnan Hospital of Wuhan University, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunogenic cell death (ICD) often results in the production and accumulation of adenosine (ADO), a byproduct that negatively impacts the therapeutic effect as well as facilitates tumor development and metastasis. Here, an innovative strategy is elaborately developed to effectively activate ICD while avoiding the generation of immunosuppressive adenosine. Specifically, ZIF‐90, an ATP‐responsive consumer, is synthesized as the core carrier to encapsulate AB680 (CD73 inhibitor) and then coated with an iron‐polyphenol layer to prepare the ICD inducer (AZTF), which is further grafted onto prebiotic bacteria via the esterification reaction to obtain the engineered biohybrid (Bc@AZTF). Particularly, the designed Bc@AZTF can actively enrich in tumor sites and respond to the acidic tumor microenvironment to offload AZTF nanoparticles, which can consume intracellular ATP (iATP) content and simultaneously inhibit the ATP‐adenosine axis to reduce the accumulation of adenosine, thereby alleviating adenosine‐mediated immunosuppression and strikingly amplifying ICD effect. Importantly, the synergy of anti‐PD‐1 (αPD‐1) with Bc@AZTF not only establishes a collaborative antitumor immune network to potentiate effective tumoricidal immunity but also activates long‐lasting immune memory effects to manage tumor recurrence and rechallenge, presenting a new paradigm for ICD treatment combined with adenosine metabolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenosineAdenosine TriphosphateImmunogenic Cell DeathImmunotherapyMiceAnimalsCell Line, TumorTumor MicroenvironmentHumansNeoplasmsNanoparticlesAntineoplastic Agents

Stichwörter der Autor:innen

ATP‐adenosine axisantitumor immunotherapybacteriaimmunogenic cell deathmetabolic therapy

Substanzen

AdenosineAdenosine TriphosphateAntineoplastic Agents

Autor:innen und Institutionen

  • Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan, 430072, P. R. China.
  • Department of Cardiology, Zhongnan Hospital, Wuhan University, Wuhan, 430071, P. R. China.

ORCID-Profile: Xian-Zheng Zhang

Förderung

  • National Key Research and Development Program of China
  • Translational Medicine and Interdisciplinary Research Joint Fund of Zhongnan Hospital of Wuhan University
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China

Zitieren

APA

Deng, X. C., Liang, J. L., Zhang, S. M., Wang, Y. Z., Lin, Y. T., Meng, R., Wang, J. W., Feng, J., Chen, W. H., & Zhang, X. Z. (2024). Interference of ATP‐Adenosine Axis by Engineered Biohybrid for Amplifying Immunogenic Cell Death‐Mediated Antitumor Immunotherapy. Advanced Materials, 36(36). https://doi.org/10.1002/adma.202405673

Vancouver

Deng XC, Liang JL, Zhang SM, Wang YZ, Lin YT, Meng R, et al. Interference of ATP‐Adenosine Axis by Engineered Biohybrid for Amplifying Immunogenic Cell Death‐Mediated Antitumor Immunotherapy. Advanced Materials. 2024;36(36). doi:10.1002/adma.202405673

BibTeX
@article{Deng2024,
  author = {Deng, Xin-Chen and Liang, Jun-Long and Zhang, Shi-Man and Wang, Yu-Zhang and Lin, Yan-Tong and Meng, Ran and Wang, Jia-Wei and Feng, Jun and Chen, Wei-Hai and Zhang, Xian-Zheng},
  title = {Interference of ATP‐Adenosine Axis by Engineered Biohybrid for Amplifying Immunogenic Cell Death‐Mediated Antitumor Immunotherapy},
  journal = {Advanced Materials},
  year = {2024},
  volume = {36},
  number = {36},
  doi = {10.1002/adma.202405673}
}
Kostenlos starten →